MedPath

Comparison between two drugs intravenous dexmedetomidine and esmolol for attenuation of sympathetic response during endotracheal extubation.

Phase 2
Conditions
Health Condition 1: K810- Acute cholecystitisHealth Condition 2: O- Medical and Surgical
Registration Number
CTRI/2022/05/042940
Lead Sponsor
Dr Rashmi Naik Bhuaarya
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

ASA Physical Status ââ?¬â?? I & II

BMI (18.5-24.9)

Patient undergoing elective surgery under general anaesthesia and endotracheal intubation

Exclusion Criteria

Patientââ?¬•s refusal

Patient with known allergy to dexmedetomidine and esmolol

Surgery lasting for more than two hour

Patient with h/o hypertension, ischaemic heart disease, aortic stenosis, left ventricular failure, atrio-ventricular conduction block sinus bradycardia, asthma, chronic obstructive pulmonary disease

Severe hepatic and renal disease

Patient receiving antihypertensives, MAO inhibitors

Pregnant and lactating woman

Cases encountered with difficult intubation

Anticipated difficult airway

Novel corona virus positive

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath